Graphical Abstract Highlights d Mitochondrial Ca 2+ uniporter complex core component senses mitochondrial ROS d MCU Cys-97 undergoes S-glutathionylation and exhibits as a higher-order oligomer d Interaction between MCU and its regulatory components is unaltered by MCU oxidation d Inflammatory/hypoxia signals promote MCU oxidation and sensitize cells to death SUMMARY Ca 2+ dynamics and oxidative signaling are fundamental mechanisms for mitochondrial bioenergetics and cell function. The MCU complex is the major pathway by which these signals are integrated in mitochondria. Whether and how these coactive elements interact with MCU have not been established. As an approach toward understanding the regulation of MCU channel by oxidative milieu, we adapted inflammatory and hypoxia models. We identified the conserved cysteine 97 (Cys-97) to be the only reactive thiol in human MCU that undergoes S-glutathionylation. Furthermore, biochemical, structural, and superresolution imaging analysis revealed that MCU oxidation promotes MCU higher order oligomer formation. Both oxidation and mutation of MCU Cys-97 exhibited persistent MCU channel activity with higher [Ca 2+ ] m uptake rate, elevated mROS, and enhanced [Ca 2+ ] m overload-induced cell death. In contrast, these effects were largely independent of MCU interaction with its regulators. These findings reveal a distinct functional role for Cys-97 in ROS sensing and regulation of MCU activity.
In Brief Dong et al. show that conserved MCU Cys-97 senses mitochondrial luminal ROS, and MCU oxidation promotes MCU higher-order oligomer formation and exhibits persistent activation of the MCU channel, elevated mitochondrial ROS, and enhanced [Ca 2+ ] m overload-induced cell death. These findings reveal a distinct functional role for Cys-97 in mROS sensing and regulation of MCU activity.
INTRODUCTION
Oxidative stress and mitochondrial calcium ([Ca 2+ ] m ) signaling are the two functional entities that have been established to often go hand in hand in order to maintain a normal cellular physiology (Brookes et al., 2004; Hamanaka and Chandel, 2010; Kiselyov and Muallem, 2016) . Paradoxically, a cell that predominantly relies on oxidative phosphorylation for its energy source always encounters the risk of heightened oxidative stress. This is due largely to the production of superoxide resulting from miscreant electrons prematurely reacting with molecular oxygen. The electron transport chain H + pumping of mitochondria is involved in regulating the major functions of the organelle, which include ATP production, the generation of reactive oxygen species (ROS), the regulation of calcium uptake, and the activation of cell death (Duchen, 2000; Glancy and Balaban, 2012; Gunter et al., 1994; Nicholls, 2005; O'Rourke, 2007; Orrenius et al., 2003; Santo-Domingo and Demaurex, 2012) . The Ca 2+ taken up by the mitochondria participates in stimulation of bioenergetics through activation of Ca 2+ -sensitive dehydrogenases to promote ATP synthesis (Denton and McCormack, 1990; Glancy and Balaban, 2012; Hajnó czky et al., 1995) . Although [Ca 2+ ] m signaling has been established to be crucial for both physiological and pathological processes (Drago et al., 2011; Rizzuto et al., 2012) , the molecular identity of the machinery was recently elucidated by genomic approaches, and several proteins have been implicated to participate in [Ca 2+ ] m uptake, including the MCU and its regulators MICU1, MCUR1, EMRE, MCUb, and MICU2 (Baughman et al., 2011; Chaudhuri et al., 2016; Csordá s et al., 2013; De Stefani et al., 2011; Kamer and Mootha, 2014; Mallilankaraman et al., 2012a Mallilankaraman et al., , 2012b Patron et al., 2014; Perocchi et al., 2010; Plovanich et al., 2013; Raffaello et al., 2013; Sancak et al., 2013) . Increasing evidence from a number of molecular, biochemical, and structural studies indicates that MCU is the pore component of the uniporter complex (Kamer and Mootha, 2015; Kirichok et al., 2004; Lee et al., 2015 Lee et al., , 2016 Oxenoid et al., 2016; Vais et al., 2016) . Mitochondria function as a sink for Ca 2+ during cellular activation and thus generate copious amounts of ROS that are important mediators of many physiological and pathological processes (Duchen, 2000) . Oxidative stress also stimulates [Ca 2+ ] m overload followed by PTP opening (Kroemer et al., 2007; Pan et al., 2013; Shanmughapriya et al., 2015a) , but it is unknown whether intracellular ROS affects [Ca 2+ ] m homeostasis by targeting MCU channels or its regulators.
Posttranslational modification (PTM) fine-tunes both physical expansion and functional activity of proteins. In the cellular system, oxidation is one of the most frequently occurring PTMs used as powerful functional on/off switch mechanisms. Cysteine (Cys) is a highly malleable amino acid susceptible to many types of oxidative PTMs (Brewer et al., 2015) . The sulfur atom of Cys provides a considerable range of chemical reactivity to the major perceived oxidative stress and offers structural flexibility in the proteome. Cys is incorporated into proteins in the free thiol (RSH) form, and thiols can be oxidized to sulfenic acids (RSO À ) intermediate to form disulfides (RSSR) and higher oxidation states (e.g., RSO 2 À ). Thus, the thiol moiety of Cys undergoes a range of chemical modifications enabling biological switching of structure and reactivity. These modifications include sulfenylation, disulfide formation, S-glutathionylation, S-nitrosylation, persulfidation, metalation, and other modifications (Go et al., 2015) . Emerging evidence suggests that Cys Ox-PTMs function as redox switches that regulate the cell's response to oxidative stimuli and may work in concert with other PTMs (such as phosphorylation, acetylation, and ubiquitination, among others) to determine the ultimate biological outcome and cell phenotype. Previous studies demonstrated that the evolutionarily conserved Cys residue in endoplasmic reticulum (ER) Ca 2+ sensor STIM1 functions as a negative regulator of STIM1/Orai1 store-operated Ca 2+ entry and endothelial functional preservation Hawkins et al., 2010; Soboloff et al., 2012) . Currently, there is a lack of knowledge on the PTMs of the core uniporter complex protein, MCU, and thereby channel regulation. Here we sought to investigate whether redox-dependent alterations in MCU potentiate persistent channel activity and affect cellular bioenergetics and cell survival.
We demonstrate that of all the cysteines that exist in human MCU, Cys-97 is a reactive thiol and undergoes S-glutathionyla-tion. To study the effects of ROS in MCU oxidation and channel activation, we used LPS-mediated inflammation and hypoxia/ reoxygenation (H/R) models of oxidative stress and found that mitochondrial-derived oxidants markedly induced MCU oxidation and augmented MCU channel current and persistent [Ca 2+ ] m uptake, whereas the [Ca 2+ ] c dynamics remained unaffected. We also found that either oxidation of MCU or mutation of Cys-97 to MCU C97A or MCU C97M resulted in a similar MCU clustering, higher-order oligomer formation, and [Ca 2+ ] m uptake phenotype. Importantly, the oxidation of Cys-97 relieves MCU from MICU1 gatekeeping regulation that results in basal [Ca 2+ ] m accumulation. These results establish that MCU oxidation induces persistent [Ca 2+ ] m uptake and perturbs mitochondrial bioenergetics and cell function.
RESULTS

Inflammatory and Hypoxia-Derived Oxidants Modulate MCU Activity through Oxidation
Mitochondria shape cellular Ca 2+ dynamics by sequestering [Ca 2+ ] c . Following GPCR or tyrosine-kinase receptor agonist stimulation, the increase in [Ca 2+ ] c is sensed by mitochondria and facilitates MCU-mediated [Ca 2+ ] c clearance (Berridge et al., 2003; Clapham, 2007) . Over a range covered by submicromolar [Ca 2+ ] c , MCU plays only a nominal role but becomes more relevant when [Ca 2+ ] c is elevated to >2 mM (Antony et al., 2016; Csordá s et al., 2013; Liu et al., 2016; Mallilankaraman et al., 2012b; Nicholls, 1978; Tsai et al., 2016) . Thus, [Ca 2+ ] c transients shape [Ca 2+ ] m dynamics and vice versa. Apart from [Ca 2+ ] c controlling MCU activity, we hypothesize that oxidative stress can also independently regulate MCU-mediated [Ca 2+ ] m uptake.
To understand the regulatory role of oxidants in modulating MCU activity, human pulmonary microvascular endothelial cells (HPMVECs) were treated with 10 mg/mL LPS for 5 hr. Following LPS treatment, cells were imaged for simultaneous measurement of [Ca 2+ ] c and [Ca 2+ ] m dynamics. HPMVECs were stimulated with the GPCR agonist thrombin (1 mU/mL), and change in [Ca 2+ ] c and [Ca 2+ ] m dynamics was measured. Both control and LPS-treated HPMVECs on stimulation with (O) Oxidative stress-induced modification of MCU complex components. Lysates were prepared, incubated with mPEG5, and western blotted with FLAG antibody (n = 3). (P) HPMVECs expressing MCU (Ad MCU) were exposed to menadione (10 mM), LPS (10 mg/mL), or BSO (200 mM). Lysates were prepared, incubated with mPEG5, and western blotted with FLAG antibody (n = 3). (Q) Cartoon depicting how the oxidation of MCU alters MCU-mediated [Ca 2+ ] m uptake during oxidative stress. (legend continued on next page) thrombin mobilized robust [Ca 2+ ] c (Figures 1A and 1B) that was indistinguishable between control and LPS-treated cells. However, strikingly, LPS treatment resulted in a sustained elevation of [Ca 2+ ] m uptake after thrombin stimulation and remained elevated above baseline ( Figures 1B and 1C) . Additionally, to assess changes in [Ca 2+ ] m dynamics by oxidants, HPMVECs and HeLa cells were transfected with the genetically encoded mitochondrial Ca 2+ sensor GCaMP2-mt. Forty-eight hours post-transfection, HPMVECs and HeLa cells were treated with LPS (5 hr) and H 2 O 2 (100 mM for 30 min), respectively. The changes in [Ca 2+ ] m dynamics were measured after stimulation with thrombin or histamine. Cells treated with LPS/H 2 O 2 resulted in sustained [Ca 2+ ] m accumulation phenotype ( Figures 1D, 1E , S1A, and S1B, available online), with no observable differences in [Ca 2+ ] c dynamics ( Figures 1F, 1G , S1C, and S1D).
It is predicted that the initial [Ca 2+ ] m uptake by LPS stimulation could enhance the production of NADH that promotes electron leak, which results in mitochondrial membrane polarization and mitochondrial ROS (mROS) production. To test whether the MCU-mediated Ca 2+ uptake is an effective signal for mROS production, we measured the mitochondrial membrane polarization in freshly isolated mouse microvascular pulmonary endothelial cells (MPMVECs) from control (VE-Cre) and endothelial-specific MCU knockout mice (MCU DEC ) . LPS stimulation promoted the mitochondrial hyperpolarization in VE-Cre MPMVECs, but not MCU DEC ( Figures 1H and 1I ), which is consistent with MCU-mediated [Ca 2+ ] m accumulation in VE-Cre MPMVECs ( Figures 1J and 1K ). Together, these data indicate that the initial MCU-mediated [Ca 2+ ] m uptake results in mROS production, and the positive feedback role of mROS could oxidatively modify the MCU complex for persistent [Ca 2+ ] m overload ( Figure 1Q ).
To further investigate whether the excessive production of mROS was responsible for the sustained [Ca 2+ ] m mobilization, we primed HPMVECs with LPS for 3 hr. LPS-challenged HPMVECs had elevated mROS as quantified by mitoSOX fluorescence and mitochondria-targeted H 2 O 2 -sensitive HyPerD-Mito ROS sensor ( Figures 1L, 1M , and S1E). Additionally, LPS stimulation did not increase mROS production in MCU DEC , further substantiating the role for MCU-mediated [Ca 2+ ] m uptake in mROS production ( Figure 1N ). Freshly isolated adult ventricular myocytes were subjected to hypoxia (2 hr) followed by reoxygenation (30 min). Similar to LPS response, cardiomyocytes exposed to H/R exhibited increased mitoSOX fluorescence, indicative of mROS production ( Figure S1F ). Consistent with increased mROS levels, the rate of [Ca 2+ ] m uptake was increased in neonatal rat ventricular myocytes (NRVMs) exposed to H/R (Figures S1G-S1J). Next we asked whether targeted scavenging of mROS by expressing the mitochondrial antioxidants MnSOD (Ad-MnSOD virus) and peroxiredoxin 3 (PRDX3) could possibly revert the sustained [Ca 2+ ] m mobilization phenotype. HPMVECs transfected with GCaMP2-mt were transduced with either Ad-MnSOD or in combination with PRDX3. Fortyeight hours post-infection/transfection, cells were treated with LPS for 5 hr, and changes in [Ca 2+ ] m uptake were measured after thrombin stimulation. Because oxidative insult-mediated intracellular ROS production is contributed by mitochondria, ectopic expression of antioxidants alleviated the sustained [Ca 2+ ] m uptake phenotype ( Figures 1D-1F , S1A, and S1B), indicating a strong link between oxidative signaling and MCU-mediated [Ca 2+ ] m uptake ( Figure 1Q ).
Having demonstrated that mROS levels can amplify MCUmediated [Ca 2+ ] m uptake, we next investigated whether uniporter complex components are sensitive to ROS. To investigate Cys modifications of MCU complex, we used a gel shift assay using methoxypolyethylene glycol-linked maleimide (mPEG5), which measures the redox changes in proteins in situ (Leichert and Jakob, 2004) . FLAG-tagged MCU, MCUb, MICU1, MCUR1, and EMRE expressing HEK293T cells were exposed to the thiol-oxidizing agent menadione for 10 min, and mPEG5 conjugation was performed ( Figures 1O and S1K ). Only a robust mPEG5conjugated MCU was resolved by western blotting following menadione treatment, suggesting at least one freely available Cys for oxidation. Although MCUb sequence alignment predicted a conserved Cys, we observed a nominal mPEG5-conjugated MCUb ( Figure S1K , blue asterisk). Similar to menadionetreated HEK293T cells, HPMVECs pretreated with LPS (10 mg/mL for 5 hr) or the glutathione-depleting agent buthionine sulfoximine (24 hr), which halts GSH synthesis, also resulted in MCU oxidation, as indicated by MCU-mPEG formation ( Figure 1P ). Additionally, NRVMs subjected to either H/R or stimulation by the b-adrenergic agonist isoproterenol also elicited considerable levels of MCU oxidation (Figures S1L and S1M). Together, these data indicate that MCU is a redox-sensitive channel, which could augment [Ca 2+ ] m accumulation during oxidative stress conditions ( Figure 1Q ).
Cys Residues of MCU Are Redox Sensors, and MCU Cys-97 Regulates I MCU , Which Controls Mitochondrial Matrix Ca 2+ Accumulation
To determine the cysteines targeted by oxidants, computational analysis of MCU protein sequence was performed. The sequence analysis identified three potentially reactive Cys residues at positions 67, 97, and 191 (human), of which Cys-97 is highly conserved ( Figure S2A ). To evaluate the importance of Cys residues in MCU channel activity and [Ca 2+ ] m uptake, we substituted an alanine residue, MCU C67A , MCU C97A , MCU C191A , and MCU CF (CF [Cys-free]) ( Figure 2A ) and examined the effect of these mutations on [Ca 2+ ] m uptake and I MCU following expression in HeLa, HEK293T, and HPMVE cells. We hypothesized that the modifications of Cys residues in MCU could modulate the MCU channel activity and thereby control MCU-mediated [Ca 2+ ] m uptake. To assess this, HeLa cells were co-transfected with MCU-mRFP, MCU C67A -mRFP, (P) Quantification of total matrix [Ca 2+ ] m released following 20 mM Ca 2+ pulse. Data are mean ± SEM; **p < 0.01; n = 4. (Q) I MCU current in mitoplasts derived from HEK293T control and MCU mutant cells. The inset is a representative western blot probed with an antibody specific for MCU. (R) I MCU densities (pA/PF) in mitoplasts derived from control vector, MCU, MCU C97A , and MCU CF . Data are mean ± SEM; ***p < 0.001; n = 5-9. MCU C97A -mRFP, MCU C191A -mRFP, and MCU CF -mRFP along with GCaMP2-mt ( Figure S2B ). After baseline recording of [Ca 2+ ] m fluorescence, GPCR agonist histamine was added. Cells transfected with MCU, MCU C67A , and MCU C191A mobilized robust [Ca 2+ ] m upon histamine stimulation and returned to baseline, representing modest [Ca 2+ ] m dynamics (Figures S2F and S2G) . In contrast, cells transfected with MCU C97A and MCU CF resulted in a phenotypic shift with elevated [Ca 2+ ] m mobilization, and fluorescence remained above the baseline, indicating increased MCU-mediated [Ca 2+ ] m uptake ( Figures 2B and 2C) , with no significant changes in [Ca 2+ ] c dynamics (Figures 2D, S2H, and S2I) and mitochondrial membrane potential (Figure S2E) in any MCU mutants.
Because the Cys-97 mutant caused sustained [Ca 2+ ] m uptake upon GPCR agonist stimulation, we next analyzed MCU-mediated matrix [Ca 2+ ] m accumulation. We tested the basal matrix [Ca 2+ ] m in HEK293T MCU, MCU C67A , MCU C97A , MCU C191A , and MCU CF cells. The basal mitochondrial matrix Ca 2+ was higher in HEK293T cells expressing MCU C97A and MCU CF (Figures 2E and 2F) . Increased accumulation of basal mitochondrial matrix Ca 2+ was also observed in HeLa and HPMVE cells stably expressing MCU C97A and MCU CF (Figures S2J-S2M ).
Our results showing that the substitution of redox-reactive Cys to an alanine mimicked the effect of oxidative conditions on MCU functions were surprising, as replacing a Cys with alanine residue is not expected to generate an oxidomimetic mutant. In the replacement to alanine, we maintain a hydrophobic nature at the Cys-97 position but prevent any new or non-native steric effects due to the truncated side chain of alanine. Nevertheless, to validate that the change in phenotype is not a consequence of the specific amino acid-type substitution (i.e., alanine incorporation at position 97), we substituted a methionine residue for Cys (MCU C97M ). To assess the effect of methionine substitution, HeLa cells were co-transfected with MCU-mRFP and MCU C97M -mRFP along with GCaMP2-mt ( Figure S2B ). HeLa cells expressing MCU C97M mutant exhibited a similar phenotype to MCU C97A ( Figures 2G and 2H ), suggesting that alanine and methionine cause a comparable phenotype, possibly due to structural perturbations at Cys-97. Consistent with MCU C97A , the MCU C97M mutant accumulated increased matrix [Ca 2+ ] m ( Figure 2I ).
Next, we asked whether sustained [Ca 2+ ] m fluorescence observed in MCU Cys mutants was due to any changes in [Ca 2+ ] m extrusion by the mitochondrial Na + /Ca 2+ exchanger. To exclude this possibility, the rate of MCU-mediated [Ca 2+ ] m uptake and NCLX-mediated [Ca 2+ ] m efflux was measured in HEK293T cells ( Figure 2J ). Consistent with the sustained increase in [Ca 2+ ] m fluorescence, the rate of MCU-mediated [Ca 2+ ] m uptake was increased in both MCU C97A and MCU C97M mutants ( Figure 2K) and S2D ). Convincingly, the Cys mutants did not alter the ER Ca 2+ content.
Next we asked whether MCU Cys mutants facilitate MCUmediated [Ca 2+ ] m uptake even at higher extramitochondrial [Ca 2+ ] to mimic oxidative stress conditions. Cells expressing MCU C97A and MCU CF showed both increased [Ca 2+ ] m uptake rate ( Figures 2M and 2N ) and total accumulated [Ca 2+ ] m under active condition ( Figures 2O and 2P) . These data demonstrate a remarkable functional sensitivity conferred by the Cys residue (MCU C97A ), thereby enhancing MCU activity and [Ca 2+ ] m accumulation.
Because MCU C97A constitutively triggered MCU-mediated [Ca 2+ ] m uptake, we next examined whether the Cys mutation in MCU can regulate I MCU . To measure I MCU , we used a mitoplast patch clamp Hoffman et al., 2013; Kirichok et al., 2004) . Compared with vector control and MCU, the I MCU of mitoplast from cells expressing MCU C97A and MCU CF was significantly higher, which correlated with increased MCU-mediated [Ca 2+ ] m uptake in these cells ( Figures 2Q and 2R ). In addition, the increased I MCU cannot be accounted for by any difference in MCU expression ( Figure 2Q , inset). We next tested whether the enhanced MCU activity was due to changes in the interactions of MCU with other uniporter complex components, including MICU1, MCUR1, EMRE, and MCUb. We found that Cys residue mutations did not abolish the homo-or heteromeric interactions ( Figures S3A-S3E ). Taken together, these data strongly support that mutation in Cys residues of MCU exhibit increased I MCU and persistent channel activity irrespective of the interaction between MCU and other uniporter complex components.
Mitochondrial-Derived Oxidants Promote S-glutathionylation of MCU at Cys-97
Having observed that oxidative stress signals promote oxidation of MCU and increase its channel activity, we investigated whether selective Cys residues residing in the MCU might become modified by ROS. To further understand how redox signaling through site-specific modifications permits an oxidant signal to be decoded into a biological response, we applied a site-specific PEGylation approach to identify the reactive cysteines in MCU. We first exposed the Flag-tagged wild-type MCU expressing HEK293T cells to menadione for various time points, followed by PEGylation with mPEG5 ( Figure 3A) . The mature N-terminal domain of MCU has three cysteines and is sensitive to oxidative stress in vivo, which elicited mPEGylation of MCU in a time-dependent manner ( Figure 3B ). Pretreatment of cells with a reducing agent (DTT) prevented the menadione-induced gel shift of MCU ( Figure 3B ). We next explored the MCU sequence alignment for Cys conservation among eukaryotic species and found that Cys-97 (human) is well conserved among higher to lower eukaryotes, and it is in spatial proximity to the MCU-regulating acidic patch (MRAP) region (Lee et al., 2016) ( Figure 3C ). To test whether Cys-97 is susceptible to oxidative modification, HEK293T cells stably expressing human MCU and MCU C97A were subjected to oxidative stress. As expected, wild-type MCU underwent substantial oxidation following exposure to menadione ( Figure 3D ). Under the same oxidation condition, MCU C97A was not affected by the oxidants (Figure 3D) , revealing the potential site for oxidative modification.
Having detected that Cys-97 undergoes oxidant-induced modification, we treated intact HEK293T cells stably expressing MCU and MCU mutants with menadione, followed by mPEGylation ( Figure 3E ). Notably, a single shifted mPEGylated band was observed in MCU, MCU C67A , and MCU C191A , but not with MCU C97A and MCU CF (Figure 3E ). To further reinforce Cys-97 as the only Cys susceptible to oxidation, HEK293T cells were treated with menadione followed by mPEGylation ( Figure 3F ). MCU C97M mutant was not oxidized with menadione, strengthening our conclusion that only the Cys residue at position 97 undergoes oxidative modifications, which correlates with our functional effects of MCU C97A and Cys-free mutant on MCU channel activity and MCU-mediated [Ca 2+ ] m uptake.
It has been established that oxidative modifications are either reversible or irreversible in cellular systems. Because MCU oxidation is reversible and menadione is known to oxidize the reduced glutathione in the cellular system, we next assessed whether Cys-97 undergoes S-glutathionylation upon oxidative stress using an antibody that recognizes this modification. We used MCU C97A mutant as a control, and this mutant protein remained non-oxidized under the same oxidation condition that elicited the wild-type MCU oxidative modification ( Figures 3G  and 3H ). To preserve the S-glutathionylation, these protein samples were separated under a non-reducing condition. This result confirms the hypothesis that Cys-97 is susceptible to S-glutathionylation.
Having demonstrated that Cys-97 is susceptible to S-glutathionylation, we sought to determine whether this modification induces structural changes within the human MCU N-terminal domain (NTD) where only Cys-97 resides (Lee et al., 2016) . We prepared uniformly 15 N-labeled recombinant MCU (residues 72-189) and subjected the isolated MCU NTD to an S-glutathionylation protocol. Both monomer and dimer bands on Coomassie blue SDS-PAGE showed a retarded migration relative to the reduced sample after our in vitro S-glutathionylation reaction, consistent with S-glutathionylation of the domain (Figure 3I , inset). The 1 H-15 N-heteronuclear single quantum coherence spectra of the protein exhibited a wide peak dispersal in the 1 H( 15 N) dimension, consistent with a well-folded b-grasp domain. Remarkably, several amide 1 H( 15 N)-specific chemical shift perturbations were observed after the addition of DTT, indicating a conformational change within the MCU NTD associated with the reversible modification ( Figures 3I and 3J ). We next assessed the structure of the human MCU NTD and relative location of the Cys-97 residue. The Cys-97 residue is located on the b3 strand and forms backbone hydrogen bonds (yellow dashed lines) with Val88 of the b2 strand to stabilize the b-grasp-like fold ( Figure 3K ). The Cys-97 thiol group is surface exposed (orange surface and orange dashed ellipse) and primed for oxidative PTMs. Thus, our in vitro data confirmed the susceptibility of the MCU NTD to S-glutathionylation, demonstrated robust conformational changes within the b-grasp fold, and showed that the structural changes associated with this oxidative modification are reversible.
On the basis of the experimental findings depicted in Figures 1  and 2 , one possibility is that oxidation of Cys-97 or mutation increases the likelihood of regulating MCU oligomerization. To test the effect of oxidation on MCU oligomerization, we performed size exclusion chromatography (fast protein liquid chromatography [FPLC]) . Our FPLC analysis revealed that MCU was eluted from monomeric to higher-order oligomeric complex, while MCU C97A and MCU C97M mutants were separated as only higher-order MCU oligomers ( Figures 4A and 4B) . We again used these conditions and exposed cells to menadione to induce oxidative stress. Analysis of the menadione-treated MCU revealed MCU higher-order oligomer formation, similar to MCU C97A and MCU C97M mutants with or without treatment (Figures 4C and 4D) . Collectively, these results suggest that oxidative or mutational perturbation of Cys-97 increased the stability of the MCU complex and promotes channel activity.
The Conserved Redox-Sensitive MCU Cys-97 Regulates MCU Complex Assembly at the Inner Mitochondrial Membrane for Ca 2+ Uptake Because mitochondrial diameter is typically 250-500 nm, which is close to the resolution limit of light microscopy, we applied multiple imaging modalities to reveal the sub-mitochondrial MCU distribution in oxidative conditions. To gain insight into mitochondrial morphology, confocal microscopy was used and live-cell images were acquired. Confocal images of GCaMP2-mt and wild-type MCU-mRFP-positive cells revealed proper mitochondrial targeting with indistinguishable signal distribution ( Figure 5A ). Strikingly, MCU mutant-positive (MCU C97A and MCU CF ) cells co-localized with GCaMP2-mt and appeared as unique globular-like structures (Figures 5B and 5C) .
To visualize the mitochondrial distribution and distinctive mitochondrial morphology exhibited by MCU and MCU C97A , we performed superresolution structured illumination microscopy (SIM) imaging to precisely identify the MCU localization. As predicted, COX8-mRFP is clearly localized in the matrix, while wild-type MCU properly targeted to mitochondrial inner membrane (Figure 5D ). Remarkably, MCU C97A mutant again resulted in globular-like morphology but targeted to the inner mitochondrial membrane ( Figure 5E ). The MCU-positive structures did not co-localize with matrix COX8-mRFP, indicating that SIM not only resolves the localization but also distinguishes mitochondrial compartmentalization. Furthermore, the co-localization analysis revealed that MCU and MCU C97A are indistinguishable, with little change in Pearson's correlation parameters (Figures 5F and 5G) . In order to study the detailed assembly and regulation mechanisms of MCU complex structures in the mitochondrion, we used photo-activated localization microscopy (PALM). HeLa cells were transfected with MCU and MCU C97A tagged with photo-switchable protein mEos3.2 (Baumgart et al., 2016) . Similar to the above-described imaging data, PALM acquisition images showed random distribution of MCU, whereas MCU C97A appeared to assemble as clusters in the globular-like inner mitochondrial membrane ( Figure 5H ). To further verify whether the distribution of oxidized MCU phenocopies the MCU C97A mutant, we performed PALM imaging in HeLa cells transfected with MCU-mEos3.2 plasmid and treated with menadione for various time points to induce oxidative stress ( Figure S4 ). Similar to MCU C97A , menadione treatment increased the clustering of wild-type MCU (Figures 5H and 5I ). Because we adapted the PALM approach for visualization of MCU clusters, we next quantified the density of clustering within a given region of inner mitochondrial membrane. MCU C97A mEos3.2 showed a high density of cluster events compared with wild-type MCU, indicating that MCU C97A mEos3.2 protein is efficiently assembled on the inner mitochondrial membrane, strongly supporting the notion of MCU higher-order oligomerization by oxidation ( Figures 5I and  5J) . Collectively, this distribution is fully in line with MCU C97Amediated higher MCU channel activity.
MCU Oxidation Drives mROS Elevation, Perturbs Cellular Bioenergetics, and Sensitizes Cells to Death
Although ROS-mediated cytotoxicity is a well-recognized phenomenon in inflammatory and ischemic conditions, the constitutive MCU-mediated [Ca 2+ ] m uptake results in [Ca 2+ ] m overload and is generally associated with excessive mROS in cells lacking an MCU gatekeeping mechanism (Mallilankaraman et al., 2012b) . Unexpectedly, here we found that sustained MCU activity and mitochondrial matrix Ca 2+ overload occur (Figures 2E and  2F) despite an intact high-affinity Ca 2+ sensing mechanism of MICU1. Next we asked whether constitutive elevation of [Ca 2+ ] m results in [Ca 2+ ] m -dependent mROS overproduction. As expected, basal mROS levels were elevated in HPMVECs stably expressing MCU C97A and MCU CF compared with control ( Figures 6A and 6B) . Ectopic expression of MnSOD in MCU mutant cells resulted in decreased MitoSOX, indicating mROS overproduction ( Figures 6A-6C) . To determine the effect of increased [Ca 2+ ] m accumulation on cellular bioenergetics, ATP levels and oxygen consumption rate (OCR) were measured in HPMVECs. In line with matrix [Ca 2+ ] m overload and increased mROS levels, ATP levels and basal and maximal OCR were significantly reduced in HPMVECs expressing MCU C97A and MCU CF (Figures 6D-6G) .
To investigate whether quenching mROS can alleviate the bioenergetic crisis, mitochondrial antioxidant enzymes (AdMnSOD, PRDX3, and a combination of MnSOD + PRDX3) were transfected in HPMVECs stably expressing control and MCU mutants ( Figure 6C ). Expression of antioxidants markedly restored basal OCR and cellular ATP levels in MCU C97A and MCU CF cells ( Figures 6D-6G ), suggesting that the chronic accumulation of mitochondrial matrix Ca 2+ promotes excessive mROS that inhibit mitochondrial OXPHOS. Additionally, because [Ca 2+ ] m accumulation regulates a range of mitochondrial enzymes that participate in NADH generation, we also assessed the basal steady-state levels of NADH in HPMVECs. The basal NADH levels are significantly lower in MCU C97A and MCU CF mutant cells ( Figure 6H ), suggesting perturbed cellular bioenergetics by oxidation of MCU and increased channel activity.
Physiological mROS are implicated in many cellular processes, including gene expression, cell growth, proliferation, and differentiation; conversely, chronic accumulation of mROS promotes cell death (Hamanaka and Chandel, 2010) . Because HPMVECs expressing MCU C97A and MCU CF have elevated mROS levels and bioenergetic crisis, we next examined the endothelial migration, a key function of angiogenesis. To determine migration, we performed scratch assay (Mallilankaraman et al., 2012a) . Endothelial migratory capacity was attenuated in HPMVECs expressing MCU C97A and MCU CF ( Figure 6I ). We next investigated whether MCU-mediated signaling primes endothelial cell activation. We assessed proinflammatory cytokine and ICAM-1 expression in control and MCU mutant cells. Persistent elevation of [Ca 2+ ] m and mROS possibly upregulates ICAM-1, TNF-a, IL1-b, and IL-6 protein and mRNA abundance in MCU mutant cells, which was further enhanced by LPS challenge ( Figures 6J-6N) . Additionally, H 2 O 2 -induced cell death was augmented in HPMVECs expressing MCU C97A and MCU CF ( Figure 6O ). Importantly, cell death was prevented in HPMVECs expressing MCU C97A and MCU CF overexpressing mitochondrial antioxidants ( Figure 6O ). Thus, our results suggest that Cys-97 in MCU is susceptible to oxidative stress conditions, increases MCU-mediated [Ca 2+ ] m uptake, elevates the accumulation of mitochondrial matrix Ca 2+ and mROS levels, causes cellular bioenergetics crisis, and sensitizes cells to death.
DISCUSSION
Reversible oxidation of proteins is essential for the proper regulation of biological functions in most eukaryotes (Hamanaka and Chandel, 2010) . Our work provides a strong foundation for understanding how mitochondria-derived oxidants regulate mitochondrial metabolic pathways that are dependent on MCU-mediated mitochondrial matrix Ca 2+ surge. Our characterization of the oxidative modification of MCU and the identification of the conserved Cys residue that is capable of undergoing S-glutathionylation, greatly influencing MCU channel activity, suggests that this modification may occur in response to both acute and chronic oxidative stress. It has been established that both [Ca 2+ ] m overload and higher mROS elevation are known to induce mitochondrial dysfunction via mPTP opening (Orrenius et al., 2003) . Because the anterograde (Ca 2+ entry) and retro-grade (ROS production) are often interdependent phenomena, we hypothesized that oxidative stress could play a positive feedback role in modulating MCU activity. Our biochemical analysis revealed that only Cys-97 of three available cysteines was susceptible to nucleophilic reaction (Figure 3) . As it has been recently demonstrated that these three cysteines are dispensable for MCU oligomerization (Lee et al., 2016; Oxenoid et al., 2016) , Cys-97 is less likely to undergo intra-or inter-molecular disulfide bond formation. Alternative oxidative modifications include sulfenic acid or S-glutathionylation formation.
Although numerous proteins undergo sulfenylation in mammalian cells, our biochemical analysis suggested that Cys-97 was not susceptible to sulfenic acid formation (undetectable). Here our studies provide striking evidence that MCU Cys-97 becomes S-glutathionylated when exposed to oxidative stress. The conjugation of glutathione causes a conformation change within the NTD and appears to promote MCU channel activity under resting state. Because the NTD of MCU is facing the matrix, it is an opportune location to sense matrix ROS to reprogram the Ca 2+ -dependent mitochondrial metabolic signals. This suggests that inflammatory or H/R stresses possibly promote mROS overproduction in the vicinity of mitochondrial matrix that perturbs the mitochondrial GSH/GSSG ratio, which results in S-glutathionylation of MCU.
S-glutathionylated MCU and MCU C97A mutant proteins are enriched as higher-order oligomers, as visualized by superresolution microscopy using SIM and PALM imaging of wild-type MCU and MCU C97A mutant. Detailed imaging and analysis revealed that wild-type MCU was randomly distributed along the inner mitochondrial membrane. In contrast, the oxidized MCU and MCU C97A mutant appeared to reorganize cristae and orderly clustered ( Figure 5H ). In images acquired with conventional microscopy, these MCU assemblies would be indistinguishable because of limited resolution. Importantly, we noticed that dual-color images of mitochondria decorated with matrix marker COX8-mRFP and MCU-GFP often displayed that MCU-GFP signal is devoid of COX8-mRFP ( Figures 5D and 5E ). Intriguingly, superresolution imaging cluster analysis and size exclusion chromatography of MCU complex separation are consistent with higher-order oligomerization and increased MCU channel activity upon post-translational oxidative modification.
Apart from the several binding partners that form the MCU protein complexes, studies have also shown that PTMs of MCU protein can also play a key role in regulating [Ca 2+ ] m levels. (D and E) HeLa cells were co-transfected with the mitochondrial matrix marker COX8-mRFP (red) and either MCU WT-GFP (D) or MCU C97A -GFP (E) (green). Samples were imaged using SR-SIM. The blue boxes mark the magnified area (right) (n = 4). (F and G) Co-localization scatterplots (F) of MCU wild-type and MCU C97A (green) show partial co-localization with COX8 (red). (G) Pearson, Manders, and overlap coefficients between MCU wild-type and COX8-RFP or MCU C97A and COX8-RFP. (H) MCU and MCU C97A were tagged with a photo-switchable protein, mEOS3.2. HeLa cells were transfected with either construct, fixed, and imaged using PALM. The blue box marks the magnified area (right). (I) Nanoclustering of MCU WT-mEOS3.2, MCU C97A -mEOS3.2, and MCU WT-mEOS3.2 treated with menadione was conducted as previously described (Baumgart et al., 2016) . The normalized density of (r/r 0 ) molecules was plotted against the relative area covered by the clusters (h). The red line fitted to the graph denotes 100% randomly distributed molecules, while true clustering has a higher density (r/r 0 ) of molecules along a higher percentage of the area covered by the clusters (h) (n = 4-9). For each condition, we randomly quantified five to ten cells for cluster analysis. (legend continued on next page) Phosphorylation of MCU S57 and S92 has been proposed to be mediated by CaMKII, while PyK2 has been implicated in the phosphorylation of MCU Y158, Y289, and Y317 to modulate MCU activity (O-Uchi et al., 2014; Joiner et al., 2012) . However, because of a lack of direct experimental evidence, it remains unclear if phosphorylation of MCU can happen in vivo. Hence, we chose to analyze the oxidative PTMs of MCU. Furthermore, it is expected that because mitochondria are the major source of intracellular ROS, the local concentration of ROS is high, and MCU could be a likely potential target for ROS. It is important to note that though MCU complex components MICU1 (seven), MCUb (four), and MCUR1 (six) contain several Cys residues ( Figure 1O ), the comprehensive mPEG conjugation analysis revealed MCU as the primary mROS sensor.
Upon oxidative stress, several ion transport proteins are either reversibly or irreversibly modified by ROS. Our previous findings demonstrated that STIM1 undergoes S-glutathionylation that promotes Orai channel opening for Ca 2+ entry, without affecting intracellular store depletion (Hawkins et al., 2010) . This supports the notion that ion channels are regulated by redox state, although the functional consequences are divergent. For example, oxidation of reactive cysteines in Orai 1 and Orai 2 channels inhibits Ca 2+ entry (Bogeski et al., 2010) . Interestingly, other intracellular channels such as ryanodine receptor, SERCA, and IP 3 R channels undergo oxidative modification that promotes activity (Adachi et al., 2004; Bogeski and Niemeyer, 2014; Porter Moore et al., 1999) . Here we highlight for the first time that S-glutathionylation of MCU substantially redistributed MCU complex and resulted in MCU channel activation. Our results also suggest that either oxidation or disruption of Cys-97 does not alter the interactions of MCU with its regulators but rather produces a conformational change within the N-terminal b-grasp fold ( Figures S3 and 3I-3K ). These findings indicate that Cys-97 is critical for producing changes in MCU oligomerization and channel activity. It is important to note that one of the mitochondrial intermembrane space proteins, MIA40, undergoes oxidative folding and serves protein import and accumulation in the IMS (Tokatlidis, 2005 ), yet it is not known whether it senses oxidative stress. Given the unique role for MCU as a rapid mitochondrial matrix ROS sensor, our data reveal that oxidative PTM controls protein architecture and MCU channel activity. Based on our data, it is plausible that MCU determines the mitochondrial matrix ROS ''set-point'' and future studies are warranted.
In summary, upon activation by endotoxin or H/R, cells produce ROS-related species that are sensed by MCU and enhance channel activity. Our results highlight both the oxidative stress-induced mitochondrial Ca 2+ dynamics and mitochondrial MCU complex distribution that modulate mitochondrial Ca 2+ homeostasis and cellular bioenergetics. Although ROS modulates MCU activity in cells, the molecular basis and functional significance of this redox regulation in vivo warrant future research. The identification of the redox-sensing role for MCU establishes a new frame of reference to ascertain how oxidative stress perturbs mitochondrial ion homeostasis. Further understanding of the mechanisms involved may contribute insight into the etiology of metabolic disorders.
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EXPERIMENTAL MODEL DETAILS
HeLa, HEK293, and COS7 cells were grown in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% FBS, 100 U/ml penicillin, and 100 mg/ml streptomycin at 37 C and 5% CO 2 . Endothelial cells were grown in ECGS supplementation condition. Ventricular cardiomyocytes from one-to two-day-old rat hearts (NRVMs) were prepared as previously described . NRVMs were cultured in Ham's F-10 supplemented with 5% fetal bovine serum (FBS) and penicillin/streptomycin (100 U/ml) at 37 C in a 95% air/5% CO 2 humidified atmosphere for 4 days. Mouse microvascular pulmonary endothelial cells (MPMVECs) were obtained from C57BL/6 endothelial-specific MCUKO mice (MCU DEC ), and control (VE-Cre) mice as described earlier.
METHOD DETAILS
Plasmids and Recombinant proteins
Plasmids pCMV6-Entry-MCU, MICU1, EMRE, MCU, and COX8A-C-mRFP were purchased from Origene Technologies. They were then subcloned in the pCMV6-AC-HA and pCMV6-AC-GFP vectors (Origene), and pCMV/Bsd (blasticidin) (Thermo Fisher Scientific) as required. The mutant MCU constructs (MCU C97A , MCU C67A , MCU C191A , MCU C97M , and MCU CF ) were custom synthesized as gBlock gene fragments from IDT Inc. and subcloned into appropriate vectors for further use. The mEOS3.2 MCU (MCU WT , MCU C97A , and MCU CF ) constructs for PALM were engineered by inserting mEOS3.2 (monomeric variant of green-to-red photoswitchable fluorescent protein EosFP, for reduced aggregation relative to mEos2 [from Michael Davidson Lab]) between the MluI and XhoI sites of pCMV6-AC-DDK vector and then the MCU WT , MCU C97A , and MCU CF were inserted into the SgfI and MluI sites. All plasmids were confirmed by sequencing before use.
Generation of stable cells expressing MCU WT , MCU C67A , MCU C97A , MCU C97M , MCU C191A and MCU CF HEK293T, HeLa, and HPMVEC cells were transfected with MCU WT , MCU C67A , MCU C97A , MCU C191A MCU C97M and MCU CF and 48 hr post-transfection, cells were selected with blasticidin (2 mg/ml) for 6-10 days and expanded. Hypoxia/Reoxygenation Exposure Freshly isolated NRVMs (rat neonates) and adult cardiomyocytes (mice) were subjected to 2 hr of hypoxia (1% O 2 -5% CO 2 ) followed by 30 min of reoxygenation (21% O 2 -5%CO 2 ) before any measurements were performed to study the role of ROS induced modification of MCU protein and channel activity.
